Status:
UNKNOWN
Comorbid Mental Disease and Heart Disease in Men
Lead Sponsor:
Universite de Moncton
Collaborating Sponsors:
Movember Foundation
New Brunswick Health Research Foundation
Conditions:
Acute Coronary Syndrome
Depressive Disorder
Eligibility:
MALE
18-95 years
Brief Summary
Mood disorders, anxiety disorders, and trauma-related stress (MD\\AD\\TRS) are common among men, particularly those suffering from heart disease (HD). MD\\AD\\TRS are significantly related to exacerba...
Detailed Description
The intervention proposed in this study is a stepped-care model comprised of three steps. The intensity of the intervention increases for participants with each of the following steps: 1) psychoeducat...
Eligibility Criteria
Inclusion
- New Brunswick, Ontario and Quebec sites:
- men with a diagnosis of ACS (Acute cardiac syndrome) : myocardial infarction such as ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation myocardial infarction (NSTEMI), or unstable angina, or angioplasty with or without a stent or coronary bypass in the last 3 months.
- able to speak or write in English or French
- with an identified treating health professional (cardiologist, family doctor or nurse practitioner).
- able to attend 8 weekly sessions if qualifies for step 2;
- available for at least one year of follow-up.
- New-Brunswick site only:
- Surgery patients (surgery in the last three months) will also be included (CABG, Percutaneous valve, Valve, Valve/Graft, Cardioverter (pacemaker), …)
- Congestive heart failure : patients with NYHA Class III or NYHA Class IV.
Exclusion
- Abuse of any substance in the past 12 months such as alcohol, cannabis, drugs as screened by the Simple Screening Instrument for Substance Abuse;
- Self-reported personal history of psychotic disorders or bipolar disorders (i.e. schizophrenia, paranoia, personality disorders
- Recently (3 months or less) started on psychotherapy or pharmacological treatment of MD/AD/TRS.
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2019
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT03354351
Start Date
December 1 2017
End Date
December 31 2019
Last Update
November 28 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.